Amani Fawzi is an Ophthalmology physician affiliated with Northwestern University. OpenAlex indexes 417 publications with 12,359 citations (h-index 58). By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
675 N Saint Clair St
Chicago, IL 606115975
Telephone
312-695-8150Registry record last updated 24 Apr 2015.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- F. Hoffmann-La Roche AGProgram year20256 payments
- Chugai Pharmaceutical Co., Ltd.Program year20251 payment
- F. Hoffmann-La Roche AGProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
86.8%Vascular Endothelial Growth Factor Inhibitor86.8%Aflibercept100%Part B, office-administered≥46 patientsMusculoskeletal
8.8%Cyclooxygenase Inhibitor8.8%Ketorolac Tromethamine100%Part D<11 patientsSensory organs
4.4%alpha-Adrenergic Agonist4.4%Brimonidine Tartrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2014–2026 per NIH RePORTER. The latest:
- Exploring the angiogenesis-to-fibrosis transition in ischemic retinopathies Renewal
Northwestern University
FY2026$667,746R01EY030121 - Cellular-level Vascular Oculomics (CVO) for monitoring systemic vascular health
Northwestern University
FY2025$1,599,916OT2OD038128 - Exploring the angiogenesis-to-fibrosis transition in ischemic retinopathies Renewal
Northwestern University
FY2025$679,986R01EY030121
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Optical coherence tomography angiography in diabetic retinopathy
Progress in Retinal and Eye Research
2023 - AI-based monitoring of retinal fluid in disease activity and under therapy
Progress in Retinal and Eye Research
2021 - Macrophage-Like Cell Density Is Increased in Proliferative Diabetic Retinopathy Characterized by Optical Coherence Tomography Angiography
Investigative Ophthalmology & Visual Science
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”